Analyst Ratings for Bright Minds Biosciences Inc. (DRUG)
DRUG Rating Summary
DRUG Price Target Summary
- Highest: $220.00 (Piper Sandler)
- Lowest: $126.00 (Baird)
- Average: $155.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$155.50 (+203.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$155.50 (+203.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
150.00 (N/A) |
50.71 (51.30) |
1.16% | Details |
| 4/13/2026 | Jefferies | Andrew Tsai | New Coverage | Buy (N/A) |
145.00 (N/A) |
85.91 (51.30) |
-40.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
